Watchlist Price Alert

Aridis Pharmaceuticals In... (ARDS)

OTC: ARDS · Real-Time Price · USD

0.00

-0.00 (-100.00%)

At close: Apr 01, 2025, 9:51 AM

Aridis Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-30.37M	-42.19M	-22.33M	-29.68M	-22.11M	-24.66M	-8.42M
Depreciation & Amortization	487K	435K	337K	338K	283K	62K	23K
Stock-Based Compensation	1.48M	2.25M	2.13M	2.01M	1.66M	1.61M	858K
Other Working Capital	2.63M	7.86M	-534K	19.58M	-97K	120K	180K
Other Non-Cash Items	577K	6.78M	9K	951K	-1.59M	5.15M	369K
Deferred Income Tax	n/a	-722K	n/a	n/a	n/a	n/a	172K
Change in Working Capital	-1.3M	10.52M	-617K	18.22M	-2.52M	277K	909K
Operating Cash Flow	-29.13M	-22.94M	-20.48M	-8.16M	-24.27M	-17.56M	-6.09M
Capital Expenditures	-82K	-530K	-367K	-174K	-677K	-698K	-15K
Cash Acquisitions	n/a	n/a	n/a	n/a	-1M	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	-1M	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	1M	n/a	n/a
Investing Cash Flow	-82K	-530K	-367K	-174K	-1.68M	-698K	-15K
Debt Repayment	3.2M	5M	715K	n/a	n/a	n/a	-300K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	-4.13M	n/a	n/a	-1.36M	n/a	n/a
Other Financial Acitivies	-1.03M	4.13M	14K	35K	1.37M	n/a	n/a
Financial Cash Flow	14.78M	34.72M	8.68M	4.99M	25.09M	21.06M	25.5M
Net Cash Flow	-14.43M	11.25M	-12.16M	-3.34M	-859K	2.81M	19.4M
Free Cash Flow	-29.21M	-23.47M	-20.84M	-8.33M	-24.95M	-18.25M	-6.11M